TipHub

₹16.8

▼ -0.19 -1.12%

As of 13 Nov 2026 · delayed

BSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-11-11

Bacil Pharma Ltd. (524516)

Volume: 2,860Avg Vol 1W: 25,998Avg Vol 1M: 14,08952W Range:₹10.65₹61.8
BSE www.bacilpharma.co.in AI Report
Key Ratios
Checked just now
Market Cap₹24 Cr
Current Price₹16.8
Previous Close₹16.99
High / Low (52w)₹61.8 / ₹10.65
Volume2,860
Avg Vol (1W)25,998
Avg Vol (1M)14,089
Stock P/E15.56
Book Value₹17.55
Dividend Yield0%
ROE276.12%
ROA-29.21%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹1.08
P/B0.96
Debt / Equity0
50 DMA₹20.68
200 DMA₹36.4
Day change-1.12%
SurveillanceESM · ESM 1
Price Chart
₹16.8▼ 45.56% · 1Y
₹60₹1115.1L
2025-11-14
2026-11-13

20-day avg volume: 15K shares

Pros
  • Healthy return on equity of 276.1%.
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026Sept 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹1 Cr₹2 Cr₹0 Cr₹0 Cr
EPS—————1.11——
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹5 Cr₹4 Cr₹4 Cr₹1 Cr₹1 Cr₹1 Cr₹26 Cr₹27 Cr
Total Liabilities₹3 Cr₹3 Cr₹3 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹3 Cr
Equity₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹25 Cr₹25 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Investing₹1 Cr₹4 Cr₹0 Cr₹0 Cr₹0 Cr₹-2 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹-1 Cr
Free Cash Flow₹0 Cr₹-4 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE0.9%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-09-30

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge—
No. of Shareholders7,691
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Jul 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters42.7%42.7%20.7%10.6%0.2%0.2%0.1%0.1%0.1%0%0%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public57.3%57.3%79.3%89.4%99.8%99.8%99.9%99.9%99.9%100%100%100%
Promoter Pledge0%0%0%0%0%0%0%0%0%———
No. of Shareholders6,7706,7946,9027,4617,6387,5327,5417,4317,4317,2267,3267,691
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Vicky Pratapbhai ShahPublic Shareholding16.6%23,81,708
Nikita Hiren PatelPublic Shareholding9.6%13,74,352
Manubhai Amrutlal ShahPublic Shareholding7.8%11,25,745
Chhaya Gaurang ShahPublic Shareholding6.4%9,17,413
Jr Seamless Private LimitedPublic Shareholding5.5%7,88,048
Manmohan Jagdishprasad GhuwalewalaPublic Shareholding4.2%6,00,000
Navin Keshrimal MehtaPublic Shareholding2.2%3,11,781
Shrynax Trading Private LimitedPublic Shareholding2.1%2,99,406
Purshottam R BohraPublic Shareholding2.1%2,94,030
Brenley Engineers Private LimitedPublic Shareholding1.8%2,55,580
Deepa Navin MehtaPublic Shareholding1.7%2,49,980
Amnesti Multiservices Private LimitedPublic Shareholding1.4%2,05,162
Saroj Kishor MehtaPublic Shareholding1.2%1,65,861
Suman P ShahShareholding of Promoter and Promoter Group0%0
Lal Lachhmandas HingoraniShareholding of Promoter and Promoter Group0%0
Prakash ShahShareholding of Promoter and Promoter Group0%0
Prakash Shah HufShareholding of Promoter and Promoter Group0%0
Shakuntala ShahShareholding of Promoter and Promoter Group0%0
Gulecha Investment & Trading Co Pvt LtdShareholding of Promoter and Promoter Group0%0
Khem Sum Apparels Overseas LimitedShareholding of Promoter and Promoter Group0%0
Sanmitra Commercial LimitedShareholding of Promoter and Promoter Group0%0
Rapport Investment & Trading Company Private LimitedShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Chaitali Kalpataru ShahExecutive Director & CFO2025
Dinesh Chander NotiyalIndependent Non Exe. Director2025
Avani Savjibhai GodhaniyaIndependent Non Exe. Director2025
Vivek Mukesh YadavIndependent Non Exe. Director2025
Tak Bhavana TakCompany Sec. & Compli. Officer2025
Aayush ShahIndependent Director2025
Ankitkumar Surendrakumar AgrawalIndependent Director2025
Mahesh SinghDirector2025
Mr. Anil Shiv Charan SinghDirector2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10201414
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
forthcoming2026-07-09Board Meetings—
Substantial Acquisitions (SAST)

10 disclosure(s)

Market22/06/2026 - 24/06/2026 · 9,25,000
Market23/06/2026 - 24/06/2026 · 3,94,893
Market22/06/2026 - 23/06/2026 · 10,19,052
Market10/06/2026 · 8,00,000
Market08/06/2026 - 09/06/2026 · 3,26,104
Off Market19/02/2026 · 20,75,000
Company Information
Incorporated1987
AuditorSarang Shivajirao Chavan & Associates
Investor Email[email protected]
🌐 www.bacilpharma.co.in ↗

📍 G2 & G3 Samarpan Complex, chakala Andheri East, Mumbai, Maharashtra, 400099

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Riddhi Siddhi Gluco Biols Ltd.SVC Industries LimitedRaaj Medisafe India Ltd.Revati Media LimitedCoral Laboratories Ltd.Tulasee Bio-Ethanol Ltd.Krebs Biochemicals & IndustriesKMC Speciality Hospitals (India) Ltd.Laffans Petrochemicals Ltd.Bhaskar Agrochemicals Ltd.Sukhjit Starch & ChemicalsSharma East India Hosp and Medical Research Ltd.All “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search